Normally when we we write about Revive Therapeutics (RVV.C), it’s generally to provide an update on their progress regarding their experimental COVID-19 palliative, Bucillamine. This update isn’t that, and…
drug delivery system
Heritage is positioning itself to radically expand its sales territory….
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”….